š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Previous studies have shown that there are alterations in the number and af...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2023-07
Trial ID
NCT05922306
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
Primary Objective: ā¢ To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
The purpose of the present trial is to evaluate 6 vaccine formulations of r...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1993-11
Trial ID
NCT00697970
Treatments Being Tested
This prospective cohort study aims to provide the evidence-based clinical g...
Status
Recruiting
Location
Family Medicine, NTUH
Start Date
2021-08-01
Trial ID
NCT04970836
Treatments Being Tested
The purposes of this study include 1) to compare the seroconversion rate of...
Status
Unknown
Location
Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University
Start Date
2011-01
Trial ID
NCT01289106
Treatments Being Tested
The purpose of this study is to determine the durability of seroprotection ...
Status
Completed
Location
Clinical Research Associates of Tidewater
Start Date
2010-12
Trial ID
NCT01282762
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00092469
The primary purpose of this study is to determine whether HepavaxGene TF is...
Status
Completed
Location
Center for Disease Control and Prevention Jiangsu Province
Start Date
2011-05
Trial ID
NCT01349283
Treatments Being Tested